Nucleocapsid Antigenemia Is a Marker of Acute SARS-CoV-2 Infection. Verkerke HP, Damhorst GL, Graciaa DS, McLendon K, et al. J Infect Dis 2022;226:1577-1587.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Verkerke HP, Damhorst GL, Graciaa DS, McLendon K, et al. Nucleocapsid Antigenemia Is a Marker of Acute SARS-CoV-2 Infection. J Infect Dis 2022;226:1577-1587.
PMID: 35877413